Ambit(美国)
Ambit Biosciences
AmbitBioscienceswww.ambitbio.com生物制药公司,致力于发现,开发和商业化的药物来治疗肿瘤,自身免疫性疾病和炎症性疾病AmbitBiosciencesisabiopharmaceuticalcompanyfocusedonthediscovery,developmentandcommercializationofdrugstotreatunmetmedicalneeds
inoncology,autoimmuneandinflammatorydiseasesbyinhibitingkinasesthatareimportantdriversforthosediseases.Ourpipelinecurrentlyincludesthreeprograms,eachaimedattheinhibitionofvalidatedkinasetargets.Ourleaddrugcandidate,quizartinib,isaonce-daily,orally-administered,potentandselectiveinhibitorofFMS-liketyrosinekinase3(FLT3),avalidatedtargetinthetreatmentofAML,andiscurrentlyinPhase2bclinicaldevelopmentinrelapsed/refractoryAMLpatientswhoexpresstheFLT3-ITDmutation(FLT3-ITDpositivepatients).TheFLT3-ITDmutationactslikea“powerswitch”thatcausesleukemiccells,orblasts,tospreadmoreaggressivelyandgrowbackmorerapidlyfollowingchemotherapy,